Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/17/2864795/0/en/Ipsen-publishes-its-2023-Universal-Registration-Document.html
https://www.globenewswire.com/news-release/2024/04/08/2859414/0/en/Ipsen-Monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital.html
https://www.ipsen.com/press-releases/ipsen-and-sutro-biopharma-announce-exclusive-global-licensing-agreement-for-an-adc-targeting-solid-tumors/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021839
https://www.globenewswire.com//news-release/2024/03/07/2842539/0/en/Ipsen-Monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital.html
https://www.globenewswire.com//news-release/2024/02/15/2829668/0/en/Ipsen-S-A-publishes-its-2023-Consolidated-Financial-Statements.html
https://investors.merrimack.com/news-releases/news-release-details/merrimack-reports-ipsen-announcement-approval-us-fda-onivyder
https://www.globenewswire.com//news-release/2024/02/08/2825672/0/en/Building-on-solid-FY-2023-results-Ipsen-anticipates-four-launches-in-2024.html
https://www.globenewswire.com//news-release/2024/02/06/2824607/0/en/Ipsen-Monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital.html